Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Grey’s Anatomy Season 22 is expanding its cast with The Sopranos alum Jamie-Lynn Sigler. According to a new report, the ...

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...

Grey’s Anatomy Season 22 is expanding its cast with The Sopranos alum Jamie-Lynn Sigler. According to a new report, the ...

Researchers at Oregon Health & Science University have identified a type of enzyme with a complicated name - cell migration ...

In 1989, one month after she got engaged, Koreen Burrow learned she has multiple sclerosis. Over the past 36 years, the ...

In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...

First Patient Expected to be Dosed Next Week with Intranasal ForalumabPET Scan Shows Presence of Untreated Neuroinflammation ...

Jamie-Lynn Sigler is returning to the small screen.

Jamie-Lynn Sigler is joining season 22 of Grey's Anatomy. The beloved Sopranos star will have a guest-starring role as Dr.

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

An actress from "The Sopranos" will be returning to acting after a three-year break to guest-star in "Grey's Anatomy" as a ...